Part-rant and part musing, will be a thread. Firstly, this is very good news even if the drug itself, Benralizumab, is in early clinical stages and as a monoclonal is tricky to manufacture and will most likely be challenged by biosimilars. And the asthma charity quoted clearly does great work. 🧵 1/n